Beta Bionics (NASDAQ:BBNX) and Baird Medical Investment (NASDAQ:BDMD) Head-To-Head Comparison

Beta Bionics (NASDAQ:BBNX) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, analyst recommendations and risk.

Valuation & Earnings

This table compares Beta Bionics and Baird Medical Investment”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beta Bionics	$100.25 million	4.81	-$73.20 million	($1.95)	-5.57
Baird Medical Investment	N/A	N/A	N/A	N/A	N/A

Baird Medical Investment has lower revenue, but higher earnings than Beta Bionics.

Analyst Ratings

This is a breakdown of current ratings and target prices for Beta Bionics and Baird Medical Investment, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beta Bionics	1	3	6	1	2.64
Baird Medical Investment	1	0	0	0	1.00

Beta Bionics currently has a consensus target price of $23.20, indicating a potential upside of 113.43%. Given Beta Bionics’ stronger consensus rating and higher probable upside, equities research analysts clearly believe Beta Bionics is more favorable than Baird Medical Investment.

Volatility & Risk

Beta Bionics has a beta of 5.6, meaning that its stock price is 460% more volatile than the S&P 500. Comparatively, Baird Medical Investment has a beta of -1.41, meaning that its stock price is 241% less volatile than the S&P 500.

Profitability

This table compares Beta Bionics and Baird Medical Investment’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Beta Bionics	-73.02%	-20.29%	-18.32%
Baird Medical Investment	N/A	N/A	N/A

Institutional & Insider Ownership

19.8% of Baird Medical Investment shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Beta Bionics beats Baird Medical Investment on 6 of the 11 factors compared between the two stocks.

About Beta Bionics

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

About Baird Medical Investment

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.